STAT News

STAT+: Merck suffers a setback in Europe over its new Keytruda formulation

In a setback for Merck, a Dutch court ordered a halt to the manufacturing and marketing of a subcutaneous formulation of Keytruda in several European countries.

By STAT News

1 min read
STAT+: Merck suffers a setback in Europe over its new Keytruda formulation
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights